Whether targeted inhibition of METTL3 can reduce the proliferation activity and invasiveness of BC cells by inhibiting DNA repair or improve the sensitivity of BC cells to DNA damage therapies (such as chemotherapy or radiotherapy) is also likely to become a new topic. This evidence concerns the gene METTL3 and breast cancer.